This company listing is no longer active
Acasti Pharma Yönetim
Yönetim kriter kontrolleri 0/4
Anahtar bilgiler
Jan D'Alvise
İcra Kurulu Başkanı
US$1.8m
Toplam tazminat
CEO maaş yüzdesi | 25.1% |
CEO görev süresi | 6.8yrs |
CEO sahipliği | 0.01% |
Yönetim ortalama görev süresi | 1.6yrs |
Yönetim Kurulu ortalama görev süresi | 1.4yrs |
CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Dec 31 2022 | n/a | n/a | -US$17m |
Sep 30 2022 | n/a | n/a | -US$17m |
Jun 30 2022 | n/a | n/a | -US$11m |
Mar 31 2022 | US$2m | US$445k | -US$10m |
Dec 31 2021 | n/a | n/a | -US$12m |
Sep 30 2021 | n/a | n/a | -US$11m |
Jun 30 2021 | n/a | n/a | -US$18m |
Mar 31 2021 | US$582k | US$428k | -US$20m |
Dec 31 2020 | n/a | n/a | US$3m |
Sep 30 2020 | n/a | n/a | -US$6m |
Jun 30 2020 | n/a | n/a | -US$21m |
Mar 31 2020 | US$2m | US$411k | -US$26m |
Dec 31 2019 | n/a | n/a | -US$56m |
Sep 30 2019 | n/a | n/a | -US$46m |
Jun 30 2019 | n/a | n/a | -US$42m |
Mar 31 2019 | US$926k | US$373k | -US$39m |
Dec 31 2018 | n/a | n/a | -US$31m |
Sep 30 2018 | n/a | n/a | -US$34m |
Jun 30 2018 | n/a | n/a | -US$20m |
Mar 31 2018 | US$891k | US$337k | -US$17m |
Mar 31 2017 | US$631k | US$275k | -US$8m |
Tazminat ve Piyasa: Jan's total compensation ($USD1.77M) is above average for companies of similar size in the Canadian market ($USD172.33K).
Tazminat ve Kazançlar: Jan's compensation has increased whilst the company is unprofitable.
CEO
Jan D'Alvise (67 yo)
6.8yrs
Görev süresi
US$1,773,841
Tazminat
Ms. Janelle D’Alvise, also known as Jan, has been an Independent Director of Spectral Medical Inc. since June 03, 2021. She is the Chairman of the board of The ObG Project. She has been the Chief Executive...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 6.8yrs | US$1.77m | 0.015% CA$ 2.8k | |
Co-Founder | 12.9yrs | US$905.45k | 0.0020% CA$ 377.0 | |
Chief Financial Officer | 2.5yrs | US$847.55k | 0% CA$ 0 | |
Chief Operating Officer of US | 1.6yrs | US$666.86k | 0% CA$ 0 | |
Chief Commercial Officer | 1.2yrs | US$403.62k | 0.29% CA$ 55.2k | |
Vice President of Quality & Compliance | 1.5yrs | Veri yok | Veri yok | |
Senior Director of Human Resources | 1.2yrs | Veri yok | Veri yok |
1.6yrs
Ortalama Görev Süresi
61yo
Ortalama Yaş
Deneyimli Yönetim: ACST's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 6.7yrs | US$1.77m | 0.015% CA$ 2.8k | |
Independent Director | 4.9yrs | US$131.60k | 0.011% CA$ 2.0k | |
Independent Director | less than a year | US$6.00k | Veri yok | |
Independent Director | 6.7yrs | US$134.10k | 0.028% CA$ 5.4k | |
Member of Scientific Advisory Board | less than a year | Veri yok | Veri yok | |
Independent Director | 1.6yrs | US$96.60k | 0% CA$ 0 | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Board | less than a year | Veri yok | Veri yok | |
Member of Scientific Advisory Board | 1.2yrs | Veri yok | Veri yok |
1.4yrs
Ortalama Görev Süresi
61yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: ACST's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.